Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

AB9080 Anti-Ryanodine Receptor 2 Antibody

View Products on Sigmaaldrich.com
AB9080
100 µL  
Purchase on Sigma-Aldrich

Special Offers

Overview

Replacement Information

Key Spec Table

Species ReactivityKey ApplicationsHostFormatAntibody Type
H, M, RICC, IHC, WBRbSerumPolyclonal Antibody
Description
Catalogue NumberAB9080
Brand Family Chemicon®
Trade Name
  • Chemicon
DescriptionAnti-Ryanodine Receptor 2 Antibody
References
Product Information
FormatSerum
HS Code3002 15 90
Control
  • Western blot = adult mouse cardiac muscle or brain (adult mouse skeletal muscle will be negative).

    IHC = adult mouse cerebellum Purkinje cells (adult mouse cerebellum granular cells will be negative).
PresentationRabbit serum. Liquid.
Quality LevelMQ100
Applications
ApplicationAnti-Ryanodine Receptor 2 Antibody is an antibody against Ryanodine Receptor 2 for use in IC, IH & WB.
Key Applications
  • Immunocytochemistry
  • Immunohistochemistry
  • Western Blotting
Application NotesWestern blot: 1:1,000 using ECL. The antibody reacts with the 500 kDa Ryanodine Receptor 2 protein. Suggested blocking buffer is 10% normal goat serum (or same host as your secondary antibody), 1% BSA in 0.1M PBS with 0.05% Tween 20. Suggested dilution buffer is 1% normal goat serum (or same host as your secondary antibody), 1% BSA in 0.1M PBS with 0.05% Tween 20. Preferred gel percentage is 4-12% gradient gel.

Immunocytochemistry: 1:1,000

Immunohistochemistry: 1:1,000 overnight at 2-8°C using a fluorescently labeled secondary antibody. Suggested fixative is 4% paraformaldehyde in 0.1M PBS (one hour). Suggested permeablization method is 0.05% Triton X-100 in dilution buffer. Suggested blocking buffer is 10% normal goat serum (or same host as your secondary antibody) and 1% BSA in 0.1M PBS. Suggested dilution buffer is 1% normal goat serum (or same host as your secondary antibody) and 1% BSA in 0.1M PBS.

Optimal working dilutions must be determined by the end user.
Biological Information
ImmunogenSynthetic peptide from the variant TM region of human Ryanodine Receptor 2.
HostRabbit
SpecificityRyanodine Receptor 2.
Species Reactivity
  • Human
  • Mouse
  • Rat
Antibody TypePolyclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThis gene encodes a ryanodine receptor found in cardiac muscle sarcoplasmic reticulum. The encoded protein is one of the components of a calcium channel, composed of a tetramer of the ryanodine receptor proteins and a tetramer of FK506 binding protein 1B proteins, that supplies calcium to cardiac muscle. Mutations in this gene are associated with stress-induced polymorphic ventricular tachycardia and arrhythmogenic right ventricular dysplasia.
Gene Symbol
  • RYR2
  • hRYR-2
  • ARVD2
  • RyR2
  • ARVC2
  • RYR-2
  • VTSIP
UniProt Number
UniProt SummaryFUNCTION: SwissProt: Q92736 # Communication between transverse-tubules and sarcoplasmic reticulum. Contraction of cardiac muscle is triggered by release of calcium ions from SR following depolarization of T- tubules (By similarity).
SIZE: 4967 amino acids; 564498 Da
SUBUNIT: Homotetramer (Potential).
SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein (Probable).
TISSUE SPECIFICITY: Heart muscle, brain (cerebellum and hippocampus) and placenta.
DEVELOPMENTAL STAGE: Expressed in myometrium during pregnancy.
DISEASE: SwissProt: Q92736 # Defects in RYR2 are the cause of familial arrhythmogenic right ventricular dysplasia 2 (ARVD2) [MIM:600996]; also known as arrhythmogenic right ventricular cardiomyopathy 2 (ARVC2). ARVD is an autosomal dominant disease characterized by partial degeneration of the myocardium of the right ventricle, electrical instability, and sudden death. It is clinically defined by electrocardiographic and angiographic criteria; pathologic findings, replacement of ventricular myocardium with fatty and fibrous elements, preferentially involve the right ventricular free wall. & Defects in RYR2 are the cause of an autosomal dominant form of stress-induced polymorphic ventricular tachycardia (VTSIP) [MIM:604772]; also known as catecholaminergic polymorphic ventricular tachycardia (CPVT). VTSIP is a genetic arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. & Defects in RYR2 are a cause of familial polymorphic ventricular tachycardia (FPVT) [MIM:192605]. FPVT is an autosomal- dominant, inherited disease with a relatively early onset and a mortality rate of approximately 30% by the age of 30 years. Phenotypically, it is characterized by salvoes of bidirectional and polymorphic ventricular tachycardias in response to vigorous exercise, with no structural evidence of myocardial disease.
SIMILARITY: SwissProt: Q92736 ## Belongs to the ryanodine receptor family. & Contains 3 B30.2/SPRY domains. & Contains 1 EF-hand domain. & Contains 5 MIR domains.
MISCELLANEOUS: The calcium release channel is modulated by calcium ions, magnesium ions, ATP and calmodulin. & The calcium release channel activity resides in the C-terminal region while the remaining part of the protein constitutes the 'foot' structure spanning the junctional gap between the SR and the T-tubule. It is possible that the foot structure interacts with the cytoplasmic region of the dihydropyridine receptor. & Ryanodine is an alkaloid that binds to the Ca- release channel in junctional SR and modulates its activity.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsMaintain at -20°C in undiluted aliquots for up to 6 months after date of receipt. Avoid repeated freeze/thaw cycles.
Packaging Information
Material Size100 µL
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
AB9080 04053252674785

Documentation

Anti-Ryanodine Receptor 2 Antibody SDS

Title

Safety Data Sheet (SDS) 

Anti-Ryanodine Receptor 2 Antibody Certificates of Analysis

TitleLot Number
RABBIT ANTI-RYANODINE RECEPTOR 2 POLYCLONAL ANTIBODY - 2446725 2446725
RABBIT ANTI-RYANODINE RECEPTOR 2 - 3500971 3500971
RABBIT ANTI-RYANODINE RECEPTOR 2 - 3885492 3885492
RABBIT ANTI-RYANODINE RECEPTOR 2 - 4278821 4278821
RABBIT ANTI-RYANODINE RECEPTOR 2 -2661309 2661309
RABBIT ANTI-RYANODINE RECEPTOR 2 -2707826 2707826
RABBIT ANTI-RYANODINE RECEPTOR 2 -2755738 2755738
RABBIT ANTI-RYANODINE RECEPTOR 2 -2776841 2776841
RABBIT ANTI-RYANODINE RECEPTOR 2 -2796348 2796348
RABBIT ANTI-RYANODINE RECEPTOR 2 -2886455 2886455

References

Reference overviewApplicationPub Med ID
Effectiveness of gene delivery systems for pluripotent and differentiated cells.
Rapti, K; Stillitano, F; Karakikes, I; Nonnenmacher, M; Weber, T; Hulot, JS; Hajjar, RJ
Molecular therapy. Methods & clinical development  2  14067  2015

Show Abstract
26052535 26052535
PCP4 regulates Purkinje cell excitability and cardiac rhythmicity.
Kim, EE; Shekhar, A; Lu, J; Lin, X; Liu, FY; Zhang, J; Delmar, M; Fishman, GI
The Journal of clinical investigation  124  5027-36  2014

Show Abstract
25295538 25295538
Effects of CaMKII-mediated phosphorylation of ryanodine receptor type 2 on islet calcium handling, insulin secretion, and glucose tolerance.
Dixit, SS; Wang, T; Manzano, EJ; Yoo, S; Lee, J; Chiang, DY; Ryan, N; Respress, JL; Yechoor, VK; Wehrens, XH
PloS one  8  e58655  2013

Show Abstract
23516528 23516528
Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.
Denda, S; Kumamoto, J; Takei, K; Tsutsumi, M; Aoki, H; Denda, M
The Journal of investigative dermatology  132  69-75  2012

Show Abstract
21881589 21881589
Localization and phenotype-specific expression of ryanodine calcium release channels in C57BL6 and DBA/2J mouse strains.
Huang, W; Xing, W; Ryskamp, DA; Punzo, C; Križaj, D
Experimental eye research  93  700-9  2011

Show Abstract
Immunofluorescence21933672 21933672
Disrupting function of FK506-binding protein 1b/12.6 induces the Ca²+-dysregulation aging phenotype in hippocampal neurons.
Gant, JC; Chen, KC; Norris, CM; Kadish, I; Thibault, O; Blalock, EM; Porter, NM; Landfield, PW
The Journal of neuroscience : the official journal of the Society for Neuroscience  31  1693-703  2011

Show Abstract
21289178 21289178
A calcium-induced calcium release mechanism supports luteinizing hormone-induced testosterone secretion in mouse Leydig cells.
Costa, RR; Varanda, WA; Franci, CR
American journal of physiology. Cell physiology  299  C316-23  2010

Show Abstract
20519450 20519450
Local Ca2+ releases enable rapid heart rates in developing cardiomyocytes.
Korhonen T, Rapila R, Ronkainen VP, Koivumäki JT, Tavi P
J Physiol  2010

Show Abstract
20211983 20211983
Physical coupling supports the local Ca2+ transfer between sarcoplasmic reticulum subdomains and the mitochondria in heart muscle.
García-Pérez, C; Hajnóczky, G; Csordás, G
The Journal of biological chemistry  283  32771-80  2008

Show Abstract
18790739 18790739
Advancing age alters the expression of the ryanodine receptor 3 isoform in adult rat superior cervical ganglia.
Vanterpool, Conwin K, et al.
J. Appl. Physiol., 101: 392-400 (2006)  2006

Show Abstract
16645194 16645194